Regarding the presence of the TNC isoforms, almost universal and high level of expression of all these isoforms in breast carcinomas coupled with their tumor-restricted distribution make them still a plausible therapeutic target for ATN-RNA, since the sequence of ATN-RNA is directed to the EGF–like domains present always in all splicing variants. The gene discussed is TNC; the disease is breast carcinoma.